logo

AFFYMETRIX(NSDQ:AFFX)
Affymetrix scientists invented the world''s first high-density microarray and began selling the first commercial microarray. Since then, Affymetrix GeneChip technology has become the industry standard in molecular biology research. Affymetrix technology is used by the world''s top pharmaceutical, diagnostic and biotechnology companies as well as leading academic, government and not-for-profit research institutes. Affymetrix'' patented photolithographic manufacturing process provides the most information capacity available today on an array, enabling researchers to use a whole-genome approach to analyzing the relationship between genetics and health.
# Employees: 1128
Address: 3420 Central Expressway,Santa Clara,CA,USA
Phone: 408 731-5000
Fax: 408-731-5380
Website: www.affymetrix.com
Email: investor@affymetrix.com
Sector: Medical
Industry: MED-BIOMED/GENE
Executive Officers
Stephen P.A. Fodor Ph.D. (Foud. Chmn.; C.E.O.)
James R. Gibson (Prin. Fin. Off.)
John C. Batty (Exe.V.P.; C.F.O.)
Susan D. Desmond-hellma nM.D. (Dir.)
John D. Diekman Ph.D. (Dir.,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 1/27/2010
Mean EPS (Next Qtr): ($0.08)
Mean EPS (Year): ($0.46)
Mean Estimate(Long Term): $22.50
P/E Ratio(Based on EPS estimate): -0.010
Number of Estimates: 9
Shares Performance
Period AFFX Compare to S&P
YTD 61.87 % 33.97 %
4 Weeks -27.55 % -28.33 %
12 Weeks -40.61 % -44.01 %
Shares Information
Analyst Coverage: Y
Avg Volume: 1367971
Shares Outstanding: 70M
Market Cap: $0.34B
52 Week High: $9.83
52 Week Low: $1.78
P/E Ratio: -0.010
PEG Ratio: -0.010
Split: On 8/22/2000 AFFX split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: 0.00 %
EPS Growth in Last Year: 23.53 %
Sales Growth in Last Quarter: -4.12 %
Sales Growth in Last Quarter: 3.99 %
Financials
Qtr Book Value: $1.18
Cash Flow/Share: $1.61
Change in Payout Ratio: -0.010
Price/Sales: 1.080
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia